Skip to content
Peptigraph home

SLU-PP-332 Dosage: Doses Studied, Units and Chart

What doses of SLU-PP-332 have been used in published research, how they convert to syringe units, and what is still unknown.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureERR agonist (not a peptide)Updated
Doses studied
None found
No dose stated in the study abstracts (PubMed search, 11 Oct 2026)
Frequency
Not reported
not stated in the study abstracts
Half-life
Not found
No published half-life found (PubMed search, 11 Oct 2026)
Vial sizes sold
5 mg

Doses used in published studies

We list a dose only when a published study used it, with the study type and the source next to it. SLU-PP-332 is not approved, so there is no official dose.

No study dose for SLU-PP-332 was found in the abstracts we summarised (PubMed search, 11 Oct 2026).

Dose to syringe units

For a 5 mg vial mixed with 2 mL of bacteriostatic water (2.5 mg/mL), on a U-100 syringe. These are reference amounts for the math, not suggested doses.

0.25 mg
10 u
0.5 mg
20 u
1 mg
40 u
2 mg
80 u
Use your own vial and water

Before anyone considers it

  • SLU-PP-332 is not FDA approved for any use.
  • Products sold as research chemicals are not checked by the FDA for identity, purity or dose.
  • Reconstitution math (mg vs mcg, units vs mL) is the most asked question in peptide forums. Check every number twice.
  • People who are pregnant, breastfeeding, or have a chronic condition need medical advice first.

The cached abstracts name no dose

The metabolic-syndrome study in obese mice gives no amount, route or frequency in its abstract.[6]

The only duration stated is 8 weeks of treatment in 21-month-old mice, with no amount.[7]

The discovery paper calls SLU-PP-332 an in vivo chemical tool, a laboratory compound rather than a medicine.[8]

Human data

The only human-derived material is pooled human liver fractions used to identify metabolites in vitro, which is not a dosing study.[9]

Drugs@FDA lists no SLU-PP-332 product, so no label supplies an amount.[10]

Common questions

How many units is 1 mg of SLU-PP-332?

It depends on the water added. A 5 mg vial with 2 mL of water gives 2.5 mg/mL, so 1 mg is 40 units on a U-100 syringe. Use the calculator for other mixes.

Is SLU-PP-332 FDA approved?

No. SLU-PP-332 is not FDA approved for any use.

What is the SLU-PP-332 dosing?

No human dosing exists. The mouse study treated 21-month-old mice for 8 weeks and its abstract gives no amount.[7]

Is there an SLU-PP-332 protocol or cycle?

No. The cited work is mouse and cell research, and Drugs@FDA lists no product.[10]

More on SLU-PP-332

Sources

  1. 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  2. 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: "SLU-PP-332"[tiab] (10 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  4. 4PubMed search: SLU-PP-332[tiab] OR SLU-PP-915[tiab] OR "ERR agonist"[tiab] AND exercise mimetic[tiab] (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: ("SLU-PP-332"[tiab] OR "SLU-PP-915"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  6. 6A Synthetic ERR Agonist Alleviates Metabolic Syndrome.The Journal of pharmacology and experimental therapeutics · 2024PMID 37739806Accessed 2 Oct 2026
  7. 7Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.The American journal of pathology · 2023PMID 37717940Accessed 2 Oct 2026
  8. 8Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.ACS chemical biology · 2023PMID 36988910Accessed 2 Oct 2026
  9. 9Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control Purposes.Drug testing and analysis · 2026PMID 41688415Accessed 2 Oct 2026
  10. 10Drugs@FDA (openFDA) search: active ingredient "SLU-PP-332"U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026

Found an error? Report a correction.